Company intelligence / Profile preview

Afya Rekod

Ownership: Private
Development stage: Other

Overview

Afya Rekod has developed and commercialized a blockchain-secured digital health data management platform enabling patients and providers to store, access, and share medical records in real time. The system supports disease tracking for conditions such as COVID‑19, HIV, Ebola, and malaria. No clinical trial results are relevant.

Modalities: DeviceNon-pharmacological therapy (digital health data management platform; not a drug or biologic company)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Governments in Africa for COVID‑19 response

Beyond the preview

Go deeper on Afya Rekod.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Afya Rekod.

Explore the full profile